![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 239/48 | |
A61K 31/506 | |||
A61P 35/00 |
(11) | Number of the document | 2493864 |
(13) | Kind of document | T |
(96) | European patent application number | 10771744.9 |
Date of filing the European patent application | 2010-10-29 | |
(97) | Date of publication of the European application | 2012-09-05 |
(45) | Date of publication and mention of the grant of the patent | 2014-10-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2010/066435 |
Date | 2010-10-29 |
(87) | Number | WO 2011/051425 |
Date | 2011-05-05 |
(30) | Number | Date | Country code |
09174619 | 2009-10-30 | EP |
(72) |
AICHHOLZ, Reiner, CH
BLASCO, Francesca, CH
BORDAS, Vincent, CH
GRAUS PORTA, Diana, CH
GUAGNANO, Vito, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | N-OXIDE OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA |
N-OXIDE OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA |